Skip to main content
Loading market data...
ETF NYSE Arca USD

Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL

Issuer: Direxion SEC registrant: Direxion Shares ETF Trust Derivatives-based
Last price 15.16 USD Change: Up +1.47 Percent change: Up +10.74%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
Unavailable
Not found in the fee data
Net assets
$20.7M
As of 31 Jul 2026
Holdings
73
As of 31 Jul 2026
12-month distribution yield
0.39%
Quarterly
Asset class
Derivatives-based
From holdings

Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Direxion. Its category is Derivatives-based. Its last price was US$15.16 on 20 Oct 2026. It reported net assets of US$20.65 million as of 31 Jul 2026. Its latest holdings report lists 73 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.0590 a unit, a 12-month distribution yield of 0.39%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

No expense ratio found

This fund's class was not in the SEC prospectus fee data sets for the last five quarters. Check the fund's latest prospectus.

Size and reporting

Net assets
$20,650,898
Total assets
$26,614,473
Holdings as of
31 Jul 2026
Report made public
28 Sep 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 73 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

PILL top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 GOLDMAN FINANCIAL GOLDMAN FINL SQ TRSRY INST 506 No identifier reported 22.36% $4.6M Short-term investment vehicles (cash funds) United States USD
2 S&P PHARMACEUTICALS SELECT INDEX SWAP No identifier reported 16.36% $3.4M Other derivatives United States USD
3 DREYFUS DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) No identifier reported 8.14% $1.7M Short-term investment vehicles (cash funds) United States USD
4 S&P PHARMACEUTICALS SELECT INDEX SWAP No identifier reported 7.41% $1.5M Other derivatives United States USD
5 CRINETICS PHARMACEUTICALS IN US22663K1079 2.77% $572K Equity (common) United States USD
6 MBX BIOSCIENCES INC US55287L1017 2.42% $500K Equity (common) United States USD
7 S&P PHARMACEUTICALS SELECT INDEX SWAP No identifier reported -2.28% -$471K Other derivatives United States USD
8 ATAIBECKLEY INC US04650F1012 2.16% $446K Equity (common) United States USD
9 Definium Therapeutics, Inc 24477V105 2.13% $440K Equity (common) Canada USD
10 GOLDMAN SACHS LIQ ES FD A GOLDMAN SACHS FIN GOV 465 INSTITUT No identifier reported 2.03% $420K Short-term investment vehicles (cash funds) United States USD
11 AMYLYX PHARMACEUTICALS INC US03237H1014 1.72% $354K Equity (common) United States USD
12 ENLIVEN THERAPEUTICS INC US29337E1029 1.68% $348K Equity (common) United States USD
13 CORCEPT THERAPEUTICS INC Corcept Therapeutics Inc. COM STK USD0.00001 US2183521028 1.67% $344K Equity (common) United States USD
14 ALUMIS INC US0223071020 1.60% $331K Equity (common) United States USD
15 NUVATION BIO INC US67080N1019 1.57% $325K Equity (common) United States USD
16 TREVI THERAPEUTICS INC US89532M1018 1.55% $320K Equity (common) United States USD
17 LIQUIDIA CORP US53635D2027 1.47% $303K Equity (common) United States USD
18 NEKTAR THERAPEUTICS US6402683063 1.42% $292K Equity (common) United States USD
19 AMNEAL PHARMACEUTICALS INC US03168L1052 1.36% $281K Equity (common) United States USD
20 BRISTOL-MYERS SQUIBB CO Bristol-Myers Squibb Company COM USD0.10 US1101221083 1.34% $276K Equity (common) United States USD
21 EDGEWISE THERAPEUTICS INC US28036F1057 1.33% $274K Equity (common) United States USD
22 OMEROS CORP US6821431029 1.32% $273K Equity (common) United States USD
23 LIGAND PHARMACEUTICALS Ligand Pharmaceuticals Incorporated 'B'COM USD0.001 US53220K5048 1.32% $272K Equity (common) United States USD
24 ELANCO ANIMAL HEALTH INC Elanco Animal Health Inc COM NPV US28414H1032 1.31% $271K Equity (common) United States USD
25 VERADERMICS INC US9229671048 1.28% $265K Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Warning: Uses derivatives

Derivative contracts in this report have a combined notional amount of 225% of net assets. The weights here show each contract's reported value, not the exposure it creates.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 75.02%
Short-term investment vehicles (cash funds) 32.53%
Other derivatives 22.08%

Country

Country by weight
CountryWeightBar
United States 127.50%
Canada 2.13%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 129.63%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 24.27%
Health Technology 2.77%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.0590
4 payments per unit
12-month yield
0.39%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
22 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.0590) ÷ latest price ($15.16) × 100 = 0.39%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (19 payments)
PILL distributions per unit by ex-date
Ex-dateAmount per unit
22 Sep 2026$0.0010
23 Jun 2026$0.0150
24 Mar 2026$0.0100
23 Dec 2025$0.0330
23 Sep 2025$0.0100
24 Jun 2025$0.0240
25 Mar 2025$0.0180
23 Dec 2024$0.0130
24 Sep 2024$0.0290
25 Jun 2024$0.0220
19 Mar 2024$0.0270
21 Dec 2023$0.0380
19 Sep 2023$0.0350
21 Jun 2023$0.0490
21 Mar 2023$0.0190
20 Dec 2022$0.0320
20 Sep 2022$0.0170
22 Jun 2022$0.0040
22 Mar 2022$0.0080

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme